세계의 흡입 및 점비 스프레이 제네릭 의약품 시장 리포트(2023년)

“Inhalation And Nasal Spray Generic Drugs Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation and nasal spray generic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation and nasal spray generic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inhalation and nasal spray generic drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Class: Corticosteroids; Bronchodilators; Antihistamines; Combinations; Decongestant Sprays

• 2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Allergic Rhinitis; Other Indications

• 3) By Patient Demographics: Geriatric Patient; Adult Patient; Pediatric Patient

• 4) By End-User: Hospitals; Homecare; Other End-Users

• Companies Mentioned: Teva Pharmaceuticals Inc.; Sandoz International GmbH; Akorn Operating Company LLC; Cipla Inc.; Apotex Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the inhalation and nasal spray generic drugs market are: Teva Pharmaceuticals Inc., Sandoz International GmbH, Akorn Operating Company LLC, Cipla Inc., Apotex Inc., Hikma Pharmaceuticals PLC., Sun Pharmaceutical Industries Limited, Nephron Pharmaceuticals Corporation, Perrigo Company PLC., Catalent Inc., Acerus Pharmaceuticals Corporation, NIPPON SHINYAKU CO Ltd., SaNOtize Research and Development Corp, and Rokote Laboratories Finland Ltd.

The global inhalation and nasal spray generic drugs market is expected to grow from $25.87 billion in 2022 to $27.65 billion in 2023 at a compound annual growth rate (CAGR) of 6.87%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The inhalation and nasal spray generic drugs market is expected to grow to $36.27 billion in 2027 at a CAGR of 7.02%.

The inhalation and nasal spray generic drugs market consists of sales of fluticasone, budesonide, beclomethasone, albuterol, epinephrine, phenylephrine hydrochloride, oxymetazoline and hydrochloride. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The inhalation and nasal spray generic drugs are used as the main delivery mechanism for drugs to treat asthma and chronic obstructive pulmonary disease (COPD). Liquid medications that one can spray into the nose are called nasal sprays. They are used to aid in the relief of nasal congestion (stuffiness). An inhaler is a device used to administer medications in the form of a spray breathed in through the mouth or nose.

North America was the largest region in the inhalation and nasal spray generic drugs market in 2022 and is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation and nasal spray generic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The various drug classes of inhalation and nasal spray generic drugs are corticosteroids, bronchodilators, antihistamines, combinations, and decongestant sprays. Corticosteroids, which include glucocorticoids and mineralocorticoids, are a group of steroid hormones produced by the adrenal cortex and are used to provide relief for inflamed areas or severe allergies, skin problems, asthma, or arthritis. These drugs are used for different indications, including asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and other indications. The patients using these drugs are geriatric, adult, and pediatric patients. The end-users are hospitals, home care, and other end-users.

The rising incidence of chronic respiratory diseases globally is expected to propel the growth of inhalation and nasal spray generic drugs. Chronic respiratory conditions affect the lungs' airways and other structures. For instance, in September 2020, according to a study report issued by American Action Forum, a nonprofit, conservative issue advocacy group, chronic illness is a significant healthcare issue since it costs the US $3.7 trillion annually, or about 19.6% of the GDP, and is rising. Therefore, the rising incidence of chronic respiratory diseases globally will help the market grow.

Strategic partnerships and collaborations have emerged as the key trends in the market. Major players operating in the inhalation and nasal spray generic drugs market are focused on partnerships and collaborations to reinforce their position. For instance, in February 2022, Glenmark Pharmaceuticals Limited, an Indian-based integrated research-based, global pharmaceutical company, partnered with SaNOtize, a Canada-based biotech company. With this collaboration, they intend to launch the Nitric Oxide Nasal Spray (NONS) in order to treat COVID-19 in adult patients in India. Also, in July 2021, Crystec Pharma, a UK-based crystal and particle engineering company, collaborated with Iconovo to formulate new innovative compounds for dry powder inhalers. Iconovo is a Sweden-based company that offers inhalation solutions for pharmaceutical companies.

In March 2022, Sandoz International GmbH, a Switzerland-based developer, manufacturer, and distributor of generic pharmaceutical products, acquired Coalesce Product Development for an undisclosed amount. With the acquisition, Sandoz has acquired Coalesce's assets and capabilities, enabling the Novartis division to expand its current line of respiratory medications and significantly increase patient access to sophisticated therapies. Coalesce Product Development is a UK-based developer of a portfolio of novel inhalation devices.

The countries covered in the Inhalation And Nasal Spray Generic Drugs market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The inhalation and nasal spray generic drugs market research report is one of a series of new reports from The Business Research Company that provides inhalation and nasal spray generic drugs market statistics, including inhalation and nasal spray generic drugs industry global market size, regional shares, competitors with a inhalation and nasal spray generic drugs market share, detailed inhalation and nasal spray generic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation and nasal spray generic drugs industry. This inhalation and nasal spray generic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Inhalation And Nasal Spray Generic Drugs Market Characteristics

3. Inhalation And Nasal Spray Generic Drugs Market Trends And Strategies

4. Inhalation And Nasal Spray Generic Drugs Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Inhalation And Nasal Spray Generic Drugs Market
• 4.2. Ukraine-Russia War Impact On Inhalation And Nasal Spray Generic Drugs Market
• 4.3. Impact Of High Inflation On Inhalation And Nasal Spray Generic Drugs Market

5. Inhalation And Nasal Spray Generic Drugs Market Size And Growth

• 5.1. Global Inhalation And Nasal Spray Generic Drugs Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Inhalation And Nasal Spray Generic Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Inhalation And Nasal Spray Generic Drugs Market Segmentation

• 6.1. Global Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Corticosteroids
• Bronchodilators
• Antihistamines
• Combinations
• Decongestant Sprays
• 6.2. Global Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Allergic Rhinitis
• Other Indications
• 6.3. Global Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Patient Demographics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Geriatric Patient
• Adult Patient
• Pediatric Patient
• 6.4. Global Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Homecare
• Other End-Users

7. Inhalation And Nasal Spray Generic Drugs Market Regional And Country Analysis

• 7.1. Global Inhalation And Nasal Spray Generic Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Inhalation And Nasal Spray Generic Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Inhalation And Nasal Spray Generic Drugs Market

• 8.1. Asia-Pacific Inhalation And Nasal Spray Generic Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Inhalation And Nasal Spray Generic Drugs Market

• 9.1. China Inhalation And Nasal Spray Generic Drugs Market Overview
• 9.2. China Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Inhalation And Nasal Spray Generic Drugs Market

• 10.1. India Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Inhalation And Nasal Spray Generic Drugs Market

• 11.1. Japan Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Inhalation And Nasal Spray Generic Drugs Market

• 12.1. Australia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Inhalation And Nasal Spray Generic Drugs Market

• 13.1. Indonesia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Inhalation And Nasal Spray Generic Drugs Market

• 14.1. South Korea Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Inhalation And Nasal Spray Generic Drugs Market

• 15.1. Western Europe Inhalation And Nasal Spray Generic Drugs Market Overview
• 15.2. Western Europe Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Inhalation And Nasal Spray Generic Drugs Market

• 16.1. UK Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Inhalation And Nasal Spray Generic Drugs Market

• 17.1. Germany Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Inhalation And Nasal Spray Generic Drugs Market

• 18.1. France Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Inhalation And Nasal Spray Generic Drugs Market

• 19.1. Eastern Europe Inhalation And Nasal Spray Generic Drugs Market Overview
• 19.2. Eastern Europe Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Inhalation And Nasal Spray Generic Drugs Market

• 20.1. Russia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Inhalation And Nasal Spray Generic Drugs Market

• 21.1. North America Inhalation And Nasal Spray Generic Drugs Market Overview
• 21.2. North America Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Inhalation And Nasal Spray Generic Drugs Market

• 22.1. USA Inhalation And Nasal Spray Generic Drugs Market Overview
• 22.2. USA Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Inhalation And Nasal Spray Generic Drugs Market

• 23.1. South America Inhalation And Nasal Spray Generic Drugs Market Overview
• 23.2. South America Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Inhalation And Nasal Spray Generic Drugs Market

• 24.1. Brazil Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Inhalation And Nasal Spray Generic Drugs Market

• 25.1. Middle East Inhalation And Nasal Spray Generic Drugs Market Overview
• 25.2. Middle East Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Inhalation And Nasal Spray Generic Drugs Market

• 26.1. Africa Inhalation And Nasal Spray Generic Drugs Market Overview
• 26.2. Africa Inhalation And Nasal Spray Generic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Inhalation And Nasal Spray Generic Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Inhalation And Nasal Spray Generic Drugs Market Competitive Landscape And Company Profiles

• 27.1. Inhalation And Nasal Spray Generic Drugs Market Competitive Landscape
• 27.2. Inhalation And Nasal Spray Generic Drugs Market Company Profiles
  • 27.2.1. Teva Pharmaceuticals Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Sandoz International GmbH
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Akorn Operating Company LLC
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Cipla Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Apotex Inc.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Inhalation And Nasal Spray Generic Drugs Market

29. Inhalation And Nasal Spray Generic Drugs Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer